MELINA drives an AI platform in nanomedicine that combines curated data, standardized experimental workflows, and advanced machine learning models to optimize therapeutic nanoparticles. The project integrates information on nanoparticle synthesis, physicochemical characterization, and biological evaluation in cellular models to identify which variables most influence efficacy and safety. It also incorporates high-throughput methods, image analysis, and Quality by Design strategies to guide the development of new formulations in a more systematic and reproducible manner. By reducing trial-and-error and sharing data and tools openly, MELINA aims to accelerate innovation in nanomedicine and strengthen translational research.